DANIEL BUTLER: Open Payments
NPI 1013320738 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$239,707 in 150 payments from 14 companies in 2025. Trend: 2023 $34,642 · 2024 $70,499 · 2025 $239,707
Speaker / faculty: $167,245Consulting: $54,914Travel & lodging: $13,425Food & beverage: $4,034Education: $90
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 45 | $65,280 |
| GENZYME CORPORATION | 27 | $63,200 |
| Galderma Laboratories, L.P. | 25 | $48,965 |
| LEO Pharma Inc. | 24 | $40,706 |
| Novartis Pharmaceuticals Corporation | 7 | $7,532 |
| ABBVIE INC. | 11 | $5,938 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $3,100 |
| SANOFI US SERVICES INC. | 1 | $2,870 |
| Arcutis Biotherapeutics, Inc. | 4 | $1,887 |
| Janssen Biotech, Inc. | 1 | $80 |
Products named: DUPIXENT, NEMLUVIO, ADBRY, RINVOQ, SPEVIGO, AYVAKIT, ANZUPGO, Zoryve.
Industry payments across CA — which companies pay providers there.
